1. Home
  2. KPRX vs SCKT Comparison

KPRX vs SCKT Comparison

Compare KPRX & SCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KPRX
  • SCKT
  • Stock Information
  • Founded
  • KPRX 1998
  • SCKT 1992
  • Country
  • KPRX United States
  • SCKT United States
  • Employees
  • KPRX N/A
  • SCKT N/A
  • Industry
  • KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • SCKT Computer Manufacturing
  • Sector
  • KPRX Health Care
  • SCKT Technology
  • Exchange
  • KPRX Nasdaq
  • SCKT Nasdaq
  • Market Cap
  • KPRX 8.6M
  • SCKT 9.8M
  • IPO Year
  • KPRX N/A
  • SCKT 1995
  • Fundamental
  • Price
  • KPRX $2.99
  • SCKT $1.19
  • Analyst Decision
  • KPRX Strong Buy
  • SCKT
  • Analyst Count
  • KPRX 1
  • SCKT 0
  • Target Price
  • KPRX $10.00
  • SCKT N/A
  • AVG Volume (30 Days)
  • KPRX 62.4K
  • SCKT 10.3K
  • Earning Date
  • KPRX 08-08-2025
  • SCKT 07-31-2025
  • Dividend Yield
  • KPRX N/A
  • SCKT N/A
  • EPS Growth
  • KPRX N/A
  • SCKT N/A
  • EPS
  • KPRX N/A
  • SCKT N/A
  • Revenue
  • KPRX $20,000.00
  • SCKT $17,750,643.00
  • Revenue This Year
  • KPRX N/A
  • SCKT $8.62
  • Revenue Next Year
  • KPRX N/A
  • SCKT N/A
  • P/E Ratio
  • KPRX N/A
  • SCKT N/A
  • Revenue Growth
  • KPRX N/A
  • SCKT 0.29
  • 52 Week Low
  • KPRX $2.51
  • SCKT $0.91
  • 52 Week High
  • KPRX $4.80
  • SCKT $1.72
  • Technical
  • Relative Strength Index (RSI)
  • KPRX 47.28
  • SCKT 50.15
  • Support Level
  • KPRX $2.96
  • SCKT $1.16
  • Resistance Level
  • KPRX $3.29
  • SCKT $1.25
  • Average True Range (ATR)
  • KPRX 0.15
  • SCKT 0.06
  • MACD
  • KPRX 0.01
  • SCKT -0.00
  • Stochastic Oscillator
  • KPRX 38.78
  • SCKT 40.91

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.

Share on Social Networks: